Table 2 from BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Table 2 from BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

<p>HRD pathogenic genomic alterations.</p>

Saved in:
Bibliographic Details
Main Author: Andre L. De Souza (22819921) (author)
Other Authors: Matthew J. Hadfield (22819924) (author), Shaolei Lu (22819927) (author), Dragan J. Golijanin (22819930) (author), Roxanne Wood (22819933) (author), Jeannine Margolis (22819936) (author), Kate Anderson (22819939) (author), Adam J. Olszewski (15129834) (author), Sheldon L. Holder (22819942) (author), Wafik S. El-Deiry (15170575) (author), Rahul R. Aggarwal (15132918) (author), Anthony E. Mega (22819945) (author), Benedito A. Carneiro (15925723) (author)
Published: 2025
Subjects:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Phase I Clinical Trials
Prostate Cancer
Small Molecule Agents
DNA-reactive agents
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items